These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical effects of brimonidine ophthalmic drops ingestion in 52 dogs. Welch SL; Richardson JA Vet Hum Toxicol; 2002 Feb; 44(1):34-5. PubMed ID: 11824775 [TBL] [Abstract][Full Text] [Related]
3. Unintentional ingestion of brimonidine antiglaucoma drops: a case report and review of the literature. Soto-Pérez-de-Celis E; Skvirsky DO; Cisneros BG Pediatr Emerg Care; 2007 Sep; 23(9):657-8. PubMed ID: 17876259 [TBL] [Abstract][Full Text] [Related]
4. Cardiorespiratory depression and hyperglycemia after unintentional ingestion of brimonidine in a neonate. Vanhaesebrouck S; Cossey V; Cosaert K; Allegaert K; Naulaers G Eur J Ophthalmol; 2009; 19(4):694-5. PubMed ID: 19551691 [TBL] [Abstract][Full Text] [Related]
5. Brimonidine tartrate poisoning in children: frequency, trends, and use of naloxone as an antidote. Lai Becker M; Huntington N; Woolf AD Pediatrics; 2009 Feb; 123(2):e305-11. PubMed ID: 19124581 [TBL] [Abstract][Full Text] [Related]
6. Apparent central nervous system depression in infants after the use of topical brimonidine. Carlsen JO; Zabriskie NA; Kwon YH; Barbe ME; Scott WE Am J Ophthalmol; 1999 Aug; 128(2):255-6. PubMed ID: 10458196 [TBL] [Abstract][Full Text] [Related]
8. Ophthalmic drops causing coma in an infant. Berlin RJ; Lee UT; Samples JR; Rich LF; Tang-Liu DD; Sing KA; Steiner RD J Pediatr; 2001 Mar; 138(3):441-3. PubMed ID: 11241061 [TBL] [Abstract][Full Text] [Related]
9. Severe Central Nervous System and Respiratory Depression in a Neonate Following Accidental Oral Ingestion of Brimonidine Tartrate. Gul F; Shah M; Waqar M; Bassi R; Shah S; Sethi N Cureus; 2024 Jun; 16(6):e63124. PubMed ID: 39055420 [TBL] [Abstract][Full Text] [Related]
10. Effect of brimonidine tartrate on ocular hemodynamic measurements. Lachkar Y; Migdal C; Dhanjil S Arch Ophthalmol; 1998 Dec; 116(12):1591-4. PubMed ID: 9869786 [TBL] [Abstract][Full Text] [Related]
11. Systemic side effects of ophthalmic drops. Levy Y; Zadok D Clin Pediatr (Phila); 2004; 43(1):99-101. PubMed ID: 14968900 [TBL] [Abstract][Full Text] [Related]
12. Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies. Walters TR Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S19-26. PubMed ID: 8970246 [TBL] [Abstract][Full Text] [Related]
13. Vitreous concentration of topically applied brimonidine tartrate 0.2%. Kent AR; Nussdorf JD; David R; Tyson F; Small D; Fellows D Ophthalmology; 2001 Apr; 108(4):784-7. PubMed ID: 11297498 [TBL] [Abstract][Full Text] [Related]
14. The short-term effect of adding brimonidine 0.2% to timolol treatment in patients with open-angle glaucoma. Yüksel N; Altintaş O; Karabaş L; Alp B; Cağlar Y Ophthalmologica; 1999; 213(4):228-33. PubMed ID: 10420106 [TBL] [Abstract][Full Text] [Related]
15. Measurement of brimonidine concentrations in human plasma by a highly sensitive gas chromatography/mass spectrometric assay. Acheampong A; Tang-Liu DD J Pharm Biomed Anal; 1995 Jul; 13(8):995-1002. PubMed ID: 8580159 [TBL] [Abstract][Full Text] [Related]
16. Effects of brimonidine on aqueous humor dynamics in human eyes. Toris CB; Gleason ML; Camras CB; Yablonski ME Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618 [TBL] [Abstract][Full Text] [Related]